Besifloxacin ophthalmic is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids). Besifloxacin is in a class of medications called fluoroquinolones. It works by killing the bacteria that cause infection.
Adverse Reactions: The most common adverse event reported in 2% of patients treated with Besivance was conjuntival redness. Other adverse events reported in patients receiving Besivance occuring in approximately 1-2% of patients included: blurred vision, eye pain, eye irritation, eye pruritus and headache.
Supplied: 7.5 mL size bottle filled with 5 mL of besifloxacin ophthalmic suspension,
Dose: Invert closed bottle and shake once before use. Instill one drop in the affected eye(s) 3 times a day, four to twelve hours apart for 7 days.
Pediatric Use: Safety and effectiveness in infants below one year of age have not been established
Pregnancy: Since there are no adequate and well-controlled studies in pregnant women, Besivance should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.